{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:46:51Z","timestamp":1786470411212,"version":"build-2736575974"},"reference-count":17,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2026,7,14]]},"DOI":"10.1136\/ejhpharm-2025-004887","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:20:17Z","timestamp":1786468817000},"page":"ejhpharm-2025-004887","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the effectiveness of clinical pharmacist supervision over protocol-based IVIG administration in a paediatric teaching hospital"],"prefix":"10.1136","author":[{"given":"Saeed","family":"Nazarian","sequence":"first","affiliation":[{"name":"School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4619-941X","authenticated-orcid":false,"given":"Behnam","family":"Imani","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Saber-Moghaddam","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ghasemi","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Mashhad University of Medical Sciences, Mashhad, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Ghavami","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Mashhad University of Medical Sciences, Mashhad, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Arasteh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran (the Islamic Republic of)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"2026081110201206000_ejhpharm-2025-004887v1.1","doi-asserted-by":"crossref","first-page":"105016","DOI":"10.1016\/j.bioorg.2021.105016","article-title":"Potential drug development and therapeutic approaches for clinical intervention in COVID-19","volume":"114","author":"Dowarah","year":"2021","journal-title":"Bioorg Chem"},{"key":"2026081110201206000_ejhpharm-2025-004887v1.2","article-title":"Pediatric Myocarditis Management With Dual Immunotherapy: A Case Report Highlighting IVIG and Methylprednisolone Efficacy","volume":"17","author":"Owdat","year":"2025","journal-title":"Cureus"},{"key":"2026081110201206000_ejhpharm-2025-004887v1.3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10238-013-0255-4","article-title":"Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute","volume":"14","author":"Prabagar","year":"2014","journal-title":"Clin Exp Med"},{"key":"2026081110201206000_ejhpharm-2025-004887v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.09.023"},{"key":"2026081110201206000_ejhpharm-2025-004887v1.5","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2025.1545788","article-title":"Glucocorticoids and immunoglobulin alone or in combination in the treatment of multisystemic inflammatory syndrome in children: a systematic review and network meta-analysis","volume":"13","author":"Lin","year":"2025","journal-title":"Front Pediatr"},{"key":"2026081110201206000_ejhpharm-2025-004887v1.6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1527514","article-title":"Infectious outcomes of a standardized subcutaneous immunoglobulin dose reduction strategy in primary immune deficiencies amid global shortage","volume":"15","author":"Moral Moral","year":"2024","journal-title":"Front Immunol"},{"key":"2026081110201206000_ejhpharm-2025-004887v1.7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.741724","article-title":"Pharmacist-Led Intervention on the Inappropriate Use of Stress Ulcer Prophylaxis Pharmacotherapy in Intensive Care Units: A Systematic review","volume":"12","author":"Xu","year":"2021","journal-title":"Front Pharmacol"},{"key":"2026081110201206000_ejhpharm-2025-004887v1.8","doi-asserted-by":"crossref","first-page":"1195732","DOI":"10.3389\/fphar.2023.1195732","article-title":"Multicenter prospective observational study on hospital pharmacist interventions to reduce inappropriate medications","volume":"14","author":"Suzuki","year":"2023","journal-title":"Front Pharmacol"},{"key":"2026081110201206000_ejhpharm-2025-004887v1.9","doi-asserted-by":"crossref","DOI":"10.3389\/jpps.2025.14295","article-title":"Optimizing stress ulcer prophylaxis practices and reducing associated costs in intensive care units: a non-randomized controlled study","volume":"28","author":"Ayhan","year":"2025","journal-title":"J Pharm Pharm Sci"},{"key":"2026081110201206000_ejhpharm-2025-004887v1.10","doi-asserted-by":"crossref","DOI":"10.1002\/pds.5853","article-title":"Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events","volume":"33","author":"Kelly","year":"2024","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026081110201206000_ejhpharm-2025-004887v1.11","doi-asserted-by":"crossref","DOI":"10.1186\/s12887-024-05185-0","article-title":"Drug-related problems among pediatric intensive care units: prevalence, risk factors, and clinical pharmacists\u2019 interventions","volume":"24","author":"Shirzad-Yazdi","year":"2024","journal-title":"BMC Pediatr"},{"key":"2026081110201206000_ejhpharm-2025-004887v1.12","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001343"},{"key":"2026081110201206000_ejhpharm-2025-004887v1.13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/08880018.2014.955620","article-title":"Correlation of serum immunoglobulins with infection-related parameters during induction chemotherapy of pediatric acute myeloid leukemia: a prospective study","volume":"32","author":"Bansal","year":"2015","journal-title":"Pediatr Hematol Oncol"},{"key":"2026081110201206000_ejhpharm-2025-004887v1.14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/MPH.0000000000001333","article-title":"Evaluating the Efficacy and Anti-infective Effect of High-dose Intravenous Immunoglobulin Adjuvant Therapy for Acquired Aplastic Anemia Children","volume":"41","author":"Bian","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"2026081110201206000_ejhpharm-2025-004887v1.15","first-page":"21","article-title":"Evaluation of rational prescription pattern of intravenous immunoglobulin (IVIG) based on FDA-approved indications among teaching hospitals in Birjand","volume":"29","author":"Abbaszadeh","year":"2022","journal-title":"J Birjand Univ Med Sci"},{"key":"2026081110201206000_ejhpharm-2025-004887v1.16","unstructured":"Mandana M , Talieh M . Drug use evaluation of human Intravenous Immunoglobulin (IVIG) in a teaching hospital in East of Iran. J Pharm Care 2018;4."},{"key":"2026081110201206000_ejhpharm-2025-004887v1.17","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.jfma.2021.02.017","article-title":"Clinical use of intravenous immunoglobulin in Taiwan: A 10-year population study","volume":"120","author":"Hsu","year":"2021","journal-title":"J Formos Med Assoc"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2025-004887","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:20:20Z","timestamp":1786468820000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2025-004887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":17,"alternative-id":["10.1136\/ejhpharm-2025-004887"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2025-004887","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}